top of page

GROWTH

Growth

AN EXPERIENCED
TEAM TO HELP
YOU GROW

Whether organic, external or through partnerships, growth is a pillar of development that must be managed. Humanim works with you to put in place the human, technical, and organizational resources that will allow you to fully deliver the potential of your growth and make it sustainable. Between speed and consolidation, find the right rhythm with Humanim!

Start now

BUILD ON YOUR INTERNAL
RESOURCES FOR GROWTH

As with any company, the internal growth of Life Sciences companies depends first and foremost on the men and women who run the company on a daily basis. This is why Humanim works with you on your corporate culture. Your transformation will only be possible if it is understood and shared, aligned with your growth strategy, and the base of your growth and evolution.

This is a state of mind that must be nurtured in employees, from the moment they are recruited, during their integration and throughout their activity. Humanim's experience and broad knowledge of the business enable to achieve rapid and sustainable growth.

AdobeStock_173568582.jpeg

Discover the "People and culture" offer to imagine a shared goal

Humanim_bandeau_degrade_bleu.jpg

YOUR EXTERNAL GROWTH
STRATEGY WITH HUMANIM

The Life Sciences markets are changing rapidly, with many new entrants. External growth therefore appears to be a strategy for rapid development and gaining market share. However, external growth involves risks that must be identified and managed.

Let's talk strategy

Clear transactions which are based on well-conducted evaluations pave the way for opportunities.

Thanks to its understanding of the various challenges of the pharmaceutical market, Humanim can help you deploy the best strategy by working on the right integration of the different cultures involved in external growth.

Discover our

"Profiling" offer

 

GROWTH IN PARTNERSHIP,
A DOUBLE WIN

Industrial partnerships are great springboards for Life Sciences companies seeking growth. There is no reasons for not entering in a growth partnership: development of new markets, access to new technologies, acquisition of specific know-how. Humanim's teams are well versed in these different situations and can help you transform industrial partnerships into development gas pedals.

Even in the pharmaceutical industry, a partnership is first and foremost a matter of human collaboration before being business, technical and scientific. Humanim helps you define a common objective and a shared vision to build trust between the various stakeholders. This can lead to a strengthening of the relationship between two companies through new collaborations.

Discover our

know-how in

partnership

MEETING YOUR CHALLENGES

PEOPLE & CULTURE

The sustained cultural transformation of a company, if it’s initially the choice of management, must belongs to each member (…)

Partnership management

Setting up strong partnerships enables to meet the innovation challenges,

in increasingly complex systems (…)

Strategy development & execution

Emergence of new internal and external technologies, competition, regulatory and economic constraints (…) 

A CROSS-FUNCTIONAL TEAM
FOR YOUR GROWTH STRATEGY

Humanim's holistic approach allows us to design and deploy a strategy tailored to your issues and situation. A team of experts will be mobilized to address all the specificities of your project: industrialization, product expertise, logistics, structure, market, marketing and human factors.

Our in-depth knowledge of the Life Sciences industry, of its players and of all the external and internal forces will guarantee optimal growth of your business.

Different profiles, all from different backgrounds, dedicated to solve problems together in a more efficient and (re)creative way.

AdobeStock_173568582.jpeg

Discover our

"Biotech Scale-Up" offer

Meet our experts

EXPERTISE PER BUSINESS DOMAINS

Humanim_slider_expertises 03.PNG

BIOTECHNOLOGY

Following the discovery of RNA, DNA and restriction enzymes, biotechnology is a constantly evolving field that is now a fundamental enabler.

bottom of page